580 related articles for article (PubMed ID: 16685321)
1. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
5. Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
Paech V; Lorenzen T; Stoehr A; Lange K; Merz H; Meigel WN; Plettenberg A
Eur J Med Res; 2002 Nov; 7(11):477-9. PubMed ID: 12568975
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
Hayami J; Okamoto H; Sugihara A; Horio T
J Dermatol; 2007 May; 34(5):320-7. PubMed ID: 17408441
[TBL] [Abstract][Full Text] [Related]
7. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Hönigsmann H; Tanew A
Br J Dermatol; 2005 Feb; 152(2):279-83. PubMed ID: 15727639
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
Babilas P; Kohl E; Maisch T; Bäcker H; Gross B; Branzan AL; Bäumler W; Landthaler M; Karrer S; Szeimies RM
Br J Dermatol; 2006 Apr; 154(4):712-8. PubMed ID: 16536815
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Chen CT; Yang H; Kuo MY; Kuo YS; Lan WH; Wang YP; Tsai T; Chiang CP
Oral Oncol; 2004 Jul; 40(6):630-7. PubMed ID: 15063392
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin distribution after topical aminolevulinic acid in a novel porcine model of sebaceous skin.
Sakamoto FH; Tannous Z; Doukas AG; Farinelli WA; Smith NA; Zurakowski D; Anderson RR
Lasers Surg Med; 2009 Feb; 41(2):154-60. PubMed ID: 19226576
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin upregulation by 5-aminolaevulinic acid-based photodynamic therapy in human skin squamous cell carcinoma cell line.
Kuhara T; Watanabe D; Akita Y; Takeo T; Ishida N; Nakano A; Yamashita N; Ohshima Y; Kawada M; Yanagishita T; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):142-6. PubMed ID: 18477133
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
16. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid.
Calzavara-Pinton PG; Venturini M; Capezzera R; Sala R; Zane C
Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):144-7. PubMed ID: 15144392
[TBL] [Abstract][Full Text] [Related]
18. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
19. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and leucocyte-endothelium interactions contribute to the delayed effects of cryotherapy on tumours in vivo.
Schacht V; Becker K; Szeimies RM; Abels C
Arch Dermatol Res; 2002 Nov; 294(8):341-8. PubMed ID: 12420102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
